Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-21

Clinical Trial Update: Comparing Post-Operative Analgesic Effects of PCAM With Dexmedetomidine 1 mcg/ml vs PCAM With Dexmedetomidine 2 mcg/ml [Phase 4]

View source ↗

Summary

Phase 4 trial comparing postoperative analgesic effects of PCAM with Dexmedetomidine at 1 mcg/mL versus 2 mcg/mL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PCAM (PCAM)

Snippet

Sponsor: Universiti Kebangsaan Malaysia Medical Centre | Conditions: Post-Operative Analgesia, Opioid Use, Unspecified | Phase 4 | Status: COMPLETED